The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?

PhD Student in Biotechnologies and Clinical Medicine at “Sapienza” University of Rome. Medical Doctor degree in 2019. My research interests are focused in ANGPTL3 functions in lipid metabolism, both in vitro and in vivo. Member of European Atherosclerosis Society (EAS) and Società Italiana per lo studio dell’Aterosclerosi (SISA). “Research starting grant awards” at Sapienza University of Rome in 2020.

Post-doctoral research position at the Department of Translational and Precision Medicine, Sapienza University of Rome (2017-present). Post-doc fellowship at Hopital Pitie Salpetriere, Sorbonne Université (October 2019-March 2021). PhD in Biomedical Technologies in Clinical Medicine (2017), Internal Medicine Specialist degree (2013) and Medical Doctor degree at Sapienza University of Rome (2007). Research efforts focused in atherosclerosis, lipid metabolism, and common and rare metabolic disorders, as well as novel therapeutic approaches to prevent cardiovascular disease. Member of European Atherosclerosis Society (EAS), Società Italiana per lo studio dell’Aterosclerosi (SISA), Società Italiana di Medicina Interna (SIMI). “Young investigator oral presentation awards” at the EAS congress (2016). “Research starting grant awards” at Sapienza University of Rome (2016). Member of the executive committee of the Young Researcher Group of SISA society (2019-present). Member of the regional executive committee of SISA society (2019-present). Associate editor for Nutrition Metabolism and Cardiovascular disease.

Post-doctoral research position at Department of Translational and Precision Medicine, Sapienza University of Rome (2015-present). PhD in Biomedical Technologies in Clinical Medicine, Sapienza University of Rome (2014). MSc in Medical, Molecular and Cellular Biotechnology, Sapienza University of Rome (2011). My research efforts are focused on understanding the genetic basis of rare lipid disorders and the polygenic nature of metabolic multifactorial diseases, such as hepatic steatosis. I also study the role of polygenic risk scores for cardiovascular disease in Hypercholesterolemia, Hyperlipidemia and Hypobetalipoproteinemia. Member of European Atherosclerosis Society (EAS) and Italian Atherosclerosis society (SISA). Young Fellows of EAS Programme (EAS) (2019-2021).

Post-doctoral research position at Department of Translational and Precision Medicine, Sapienza University of Rome (2020-present). Post-doctoral Research position at Department of Internal Medicine and Allied Specialties, Sapienza University of Rome (2014-2019). PhD in Genetic and clinical Medicine at Sapienza University of Rome (2012). BSc degree in Genetic and Molecular Biology in 2008. My interests are focused on explaining the genetics of rare or polygenic lipid disorders, particularly in Familial Combined Hypolipidemia (FHBL2) and Familial Hypercolesterolemia (FH). Member of European Atherosclerosis Society (EAS) and Società Italiana per lo studio dell’Aterosclerosi (SISA).

Assistant Professor at Sapienza University of Rome since 2019. PhD in Biomedical Technologies in Clinical Medicine, Sapienza University of Rome in 2017. MSc in Molecular Biology in 2012. My research efforts are focused in endocrine and metabolic disorders, especially concerning thyroid cancer: the role of miRNAs and significance of extracellular vesicles in thyroid cancer progression. Member of Italian Thyroid Cancer Observatory (ITCO) foundation.

Full professor of internal medicine at Sapienza University of Rome since 2019. Research efforts focused in atherosclerosis, lipid metabolism, common and rare metabolic disorders, novel therapeutic approaches to prevent cardiovascular disease with particular interest in understanding the role of ANGPTLs, mainly ANGPTL3 in lipid metabolism and consequences of its inhibition in humans. Member of European Atherosclerosis Society (EAS), Società italiana di Medicina Interna (SIMI) and president of Società Italiana per lo studio dell’Aterosclerosi (SISA).